PlateletBio
Uma Lakshmipathy has over 17 years of experience in cell biology, stem cells and translational research. She is currently the Director of R&D at Thermo Fisher Scientific, driving key initiatives and new product development in stem cells, cell & gene therapy. Her work is focused on development of clinical-grade reagents and processes, viral and non-viral methods of cell modification and, analytical platforms for comprehensive cell therapy product characterization. Uma was previously at University of Minnesota Stem Cell Institute involved in non-viral gene transfer and ex vivo repair of stem cells for monogenic disorders. She has a doctoral degree in Molecular Biophysics from the Center for Cellular and Molecular Biology in India, postdoctoral experience in DNA double strand break repair from University of Minnesota Medical School and, has authored several scientific publications, books and patents.
This person is not in the org chart
This person is not in any offices
PlateletBio
PlateletBio is the only allogeneic cell therapy company focused on platelet biology. The company's approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, they're developing a superior cell therapy empowered to tackle previously unmet medical challenges.